By Kelly Knaub ( December 8, 2015, 9:56 PM EST) -- The European Patent Office has upheld the validity of a patent on Teva Pharmaceutical Industries Ltd.'s multiple sclerosis drug Copaxone in an oral ruling, according to a U.S. Securities and Exchange Commission filing by Teva....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.